Ascendis Pharma AS (A71) — Strategic Asset Allocation Index
Ascendis Pharma AS (A71) has a Strategic Asset Allocation Index of 4.8% as of March 2026. Strategic assets (PP&E of €- plus long-term investments of €23.56 Million) total €23.56 Million, measured against net assets of €487.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Ascendis Pharma AS Strategic Asset Allocation Index (2016–2022)
This chart shows how Ascendis Pharma AS's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of March 2026, the index stands at 4.8%, representing strategic assets of €23.56 Million against net assets of €487.97 Million EUR. Explore A71 cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Ascendis Pharma AS (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ascendis Pharma AS from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Ascendis Pharma AS.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.6% | €30.42 Million | €- | €30.42 Million | €263.35 Million | ▼ -19.2 pp |
| 2021 | 30.8% | €271.95 Million | €126.05 Million | €145.91 Million | €883.63 Million | ▲ +3.0 pp |
| 2020 | 27.7% | €232.57 Million | €108.11 Million | €124.46 Million | €838.71 Million | ▲ +17.6 pp |
| 2019 | 10.1% | €60.61 Million | €45.07 Million | €15.54 Million | €597.11 Million | ▲ +2.5 pp |
| 2018 | 7.6% | €21.41 Million | €4.33 Million | €17.08 Million | €280.05 Million | ▲ +6.3 pp |
| 2017 | 1.4% | €2.56 Million | €2.56 Million | €0.00 | €187.21 Million | ▲ +0.0 pp |
| 2016 | 1.3% | €2.35 Million | €2.35 Million | €- | €176.61 Million | — |